Elevance Health stock (US2855211023): steady NYSE performance as investors digest guidance and valuation metrics

Elevance Health shares have been trading steadily on the NYSE around the upper USD 380s to low USD 390s this week as investors weigh the health insurer’s updated guidance, recent earnings strength and valuation multiples ahead of the next catalyst.

Elevance Health shares on the New York Stock Exchange have been changing hands in the upper USD 380s to low USD 390s area this week, with one recent quote showing the stock at about USD 389 to USD 392 and a modest gain of around 0.2% to 0.3% in the latest trading session, underscoring relatively stable price action in the United States health insurance giant after its latest earnings and guidance updates, according to data from a US trading platform as of late May 2026 and a US market news site reporting a close around USD 392.47 on 05/28/2026.

The stock, which trades on the NYSE under the ticker ELV and is a constituent of major US healthcare benchmarks, has been supported by the company’s earlier decision this year to raise its earnings guidance following stronger-than-expected quarterly results, an update that continues to frame how US investors assess Elevance Health’s earnings power and capital allocation plans in its home market of the United States.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Elevance Health
• Sector/industry: Managed care and health insurance
• Headquarters/country: Indianapolis, United States
• Core markets: Commercial, government and specialty health plans across the United States
• Key revenue drivers: Premiums from medical and specialty insurance, Medicare and Medicaid plans, and affiliated healthcare services
• Home exchange/listing venue: New York Stock Exchange (ELV)
• Trading currency: USD

Elevance Health: core business model

Elevance Health operates as a large US managed care and health benefits company, generating the bulk of its revenue from insurance premiums and related healthcare services sold to commercial clients, government programs and individual members across multiple brands in the United States.

Valuation metrics and multiples for Elevance Health

Based on recent market information from a US trading platform in late May 2026, Elevance Health is valued at a market capitalization of roughly USD 84.5 billion, trades on a price-to-earnings ratio of about 16.7 times, and offers a dividend yield around 1.7%, placing the stock in a mid-teens earnings multiple range that investors commonly associate with established US managed care companies.

The same source indicates that the shares recently traded around USD 389 per share, remaining within a relatively narrow intraday range and modestly above the session low but slightly below the session high, a pattern that suggests investors are balancing the company’s raised guidance and long-term revenue targets against broader US healthcare sector sentiment when evaluating the current valuation.

Conclusion

Elevance Health’s stock is trading steadily on the NYSE in late May 2026, with only modest day-to-day moves as investors in the United States digest the company’s updated guidance and prior earnings performance in the managed care sector.

Against this backdrop, the current valuation multiples, including a mid-teens price-to-earnings ratio and a dividend yield in the low single digits, provide a structured framework for how market participants compare Elevance Health to other large US health insurers when considering future earnings trajectories and potential sector-specific catalysts.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.